8593:TSEMitsubishi HC Capital Inc. Analysis
Data as of 2026-07-26 - not real-time
¥1,439.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Mitsubishi HC Capital is trading at ¥1,439, just shy of its technical resistance of ¥1,444, while the 14‑day RSI sits at a lofty 68.7, indicating near‑overbought conditions. The MACD remains bullish (histogram +7.1) and the 20‑day SMA (¥1,378) is comfortably below the current price, supporting the short‑term upside bias, yet the price‑to‑earnings multiple of 12.8 is well below the industry average of 17.8, suggesting a valuation edge.
However, the balance sheet raises red flags: a debt‑to‑equity ratio of nearly 500× and a massive operating cash‑flow deficit of ¥367 bn offset a modest free‑cash‑flow surplus, casting doubt on the sustainability of the 3.6% dividend (payout ratio ~41%). Low beta (0.14) and stable volume temper market‑risk concerns, but 30‑day volatility of 17.4% and a max drawdown of –18% highlight price sensitivity. Overall, the stock offers attractive yield and relative cheapness but is weighed down by leverage and cash‑flow weakness.
However, the balance sheet raises red flags: a debt‑to‑equity ratio of nearly 500× and a massive operating cash‑flow deficit of ¥367 bn offset a modest free‑cash‑flow surplus, casting doubt on the sustainability of the 3.6% dividend (payout ratio ~41%). Low beta (0.14) and stable volume temper market‑risk concerns, but 30‑day volatility of 17.4% and a max drawdown of –18% highlight price sensitivity. Overall, the stock offers attractive yield and relative cheapness but is weighed down by leverage and cash‑flow weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just below resistance at ¥1,444
- High RSI (68.7) indicating overbought pressure
- Bullish MACD supporting limited upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- PE well below industry average, implying valuation upside
- Attractive dividend yield of 3.6% with reasonable payout ratio
- Low beta and stable trading volume suggest steady market support
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Extremely high debt‑to‑equity ratio limiting financial flexibility
- Negative operating cash flow raises sustainability concerns
- Diversified global footprint mitigates single‑region exposure
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin7.32%
P/E Ratio12.8
ROE8.54%
ROA1.21%
Debt/Equity493.99
P/B Ratio1.0
Op. Cash Flow¥-367536996352
Free Cash Flow¥1.9B
Industry P/E17.8
Technical Analysis
TrendNeutral
RSI68.7
Support¥1,301.00
Resistance¥1,444.00
MA 20¥1,377.75
MA 50¥1,338.24
MA 200¥1,343.08
MACDBullish
VolumeStable
Fear & Greed Index88.25
Valuation
Target Price¥1,408.33
Upside/Downside-2.13%
GradeUndervalued
TypeValue
Dividend Yield3.61%
Risk Assessment
Beta0.14
Volatility17.41%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.